Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


Cancer Vaccines

19 Sep 2012 - 20 Sep 2012 - London, UK



Bookmark and Share


SMi is proud to present their inaugural conference on Cancer Vaccines. This new and exciting event will bring together senior Pharma representatives and key academics to discuss current developments of cancer immunotherapeutics, engineering vaccine adjuvant formulations, advances and challenges in the advancement of novel therapeutic cancer vaccines and much more.

 

With presentations from industry representatives from the top 50 pharmaceutical companies, this event promises to be a unique platform for networking, and learning from case studies and problem solving.

 

Key Benefits of Attending:

 

Consider novel combination therapies in cancer vaccine development

Understand effective process development strategies

Evaluate developments in cell based immunotherapeutics

Discover strategies to improve success and overcome current issues in clinical

trials

Learn about clinical and regulatory design of immunotherapy programs

Hear from the industry on updates on the most recent successful candidates in

Phase III

Develop monitoring immunotherapy outcomes


For more information visit http://www.smi-online.co.uk/goto/cancervaccinesevent18.asp  or contact Lewis Garfield on lgarfield@smi-online.co.uklace Text Here



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!